MEMana Espahbodi

Mana Espahbodi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mana Espahbodi has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Neil S. Patel

    Department of Otolaryngology–Head and Neck Surgery, University of Utah, Salt Lake City, Utah

    7 shared publications
  • Richard K. Gurgel

    Department of Otolaryngology–Head and Neck Surgery, University of Utah, Salt Lake City, Utah

    4 shared publications
  • Richard Klaus Gurgel

    Department of Otolaryngology‐Head and Neck Surgery University of Utah Salt Lake City Utah USA

    4 shared publications
  • Evan L. Tooker

    Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, Pennsylvania

    3 shared publications
  • Robert H. Chun

    Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI, USA; Children's Wisconsin, Milwaukee, WI, USA

    3 shared publications
  • Samira Takkoush

    Department of Otolaryngology – Head & Neck Surgery University of Utah Utah USA

    3 shared publications

Latest Publications

  • Open Access

    Non-paraganglioma Jugular Foramen Tumors

    by Andrew J. Thomas, Mana Espahbodi, Clough Shelton, Richard K. Gurgel

    Jugular paragangliomas are the most common primary tumors of the jugular foramen. However, other lesions, such as jugular foramen schwannomas and meningiomas, collectively represent about 20% of tumors developing in this region. The current chapter focuses on primary non-paraganglioma jugular foramen tumors, including schwannomas, meningiomas, and metastatic lesions to the jugular foramen. For each of these tumor types, the epidemiology, clinical presentation, diagnosis, and treatment specific to each tumor are reviewed.

  • Early Identification and Management of Congenital Cytomegalovirus

    by Lauren M. Boeckermann, Mana Espahbodi, Richard K. Gurgel

  • Pediatric Cochlear Implantation for Single-Sided Deafness After Temporal Bone Fracture

    by Taylor J. Mendenhall, Eric E. Babajanian, Cody M. Anderson, Cache L. Pitt, Evan L. Tooker, Matthew L. Carlson, Neil S. Patel, Richard K. Gurgel, Mana Espahbodi

    Objective: To examine the benefit of cochlear implantation (CI) in pediatric patients with a history of temporal bone fracture resulting in single-sided deafness (SSD). Study design: Retrospective chart review. Setting: Two tertiary academic centers. Patients: Pediatric patients less than 18 years of age with SSD secondary to temporal bone fracture who underwent CI from 2012 to 2022. Intervention(s): CI. Main outcome measure(s): Postoperative audiometric testing. Results: Seven subjects were identified (median age: 10 years (y); Q1 to Q3: 5 to 16 y). Median time from temporal bone trauma to CI was 7 months (mo) (Q1 to Q3: 3 to 7 mo) and 85% had otic capsule involvement. Subjects were followed for a median length of 12 months (Q1 to Q3: 6 to 24 mo) after CI. All patients achieved full electrode insertion, though 2 required scala vestibuli insertion due to ossification of the scala tympani (one of whom had a history of meningitis after temporal bone fracture). Postoperative audiometric testing revealed variable speech perception outcomes with 4 of 7 obtaining open or closed set speech perception and 3 of 7 obtaining only sound awareness. No postoperative complications occurred. Conclusions: CI is a feasible intervention for SSD following pediatric temporal bone fractures, but outcomes are variable. Early evaluation and timely CI, ideally within 6 months of temporal bone fracture, may optimize outcomes. Cochlear ossification, either as a result of otic capsule fracture or subsequent meningitis, may lead to suboptimal outcomes.

  • Open Access

    Long‐Term Outcomes of Adult Temporal Bone Fractures With Hearing Loss: Results of a Multinational Database Analysis

    by Jason L. Steele, Heather J. Smith, Samira Takkoush, Jumah G. Ahmad, Zachary D. Urdang, Neil S. Patel, Richard K. Gurgel, Mana Espahbodi

    Objective: Temporal bone fractures (TBFs) can result in long‐term adverse outcomes including meningitis, facial nerve disorders (FNDs), and hearing loss (HL) that may require surgical intervention. This epidemiologic study aims to examine the sequelae of adult TBF with HL, including the utilization of cochlear implantation (CI), using data from a large, multinational database.Methods: Using the TriNetX database, a retrospective cohort study was performed of adults (≥ 18 years) using ICD10 codes for other fractures of the base of the skull and hearing loss, an approximation of TBF with hearing loss. A control group of adults without TBF was used. Measured outcomes included meningitis, CI, FND, cerebrospinal fluid (CSF) leak, and labyrinthitis. Propensity score matching (1:1) was used for cohorts smaller than 33,333,333. Ninety‐five percent of patient data used was from 2006 to 2023.Results: Adults with TBF and HL (n = 34,878) had a greater risk of meningitis any time after TBF than those without TBF (n = 105,035,185) (RR: 6.65, 95% CI: 5.74–7.70). Labyrinthitis (RR: 3.56, 95% CI: 2.86–4.41), CSF leak (RR: 40.71, 95% CI: 37.91–43.71), and FND (RR: 12.08, 95% CI: 11.62–12.55) were more common after TBF. CI was more common after TBF (RR: 26.22, 95% CI: 22.12–31.07). Meningitis after TBF was associated with an increased risk of CSF leak (RR: 3.0, 95% CI: 1.52–5.93) compared to those without meningitis.Conclusion: Adults who sustain TBFs resulting in HL have an increased risk of developing meningitis, labyrinthitis, CSF leak, and FND and are more likely to undergo CI for aural rehabilitation compared to a control cohort.Level of Evidence: Level IV.


  • Open Access

    Access to Cochlear Implantation: Trends in Surgeon Volume and Training

    by Mana Espahbodi, Patricia Trautwein, Daniel E. Bestourous, Teresa A. Zwolan, Ashley M. Nassiri, Matthew L. Carlson, Isaac D. Erbele, Neil S. Patel, Richard K. Gurgel

    Objectives: Evaluate the training background of surgeons performing high volumes of cochlear implants (CIs) and estimate the ratio of providers trained in otology/neurotology (O&N) to the number of traditional CI candidates and audiologists.Methods: A retrospective review of US surgeon registration data from a single CI manufacturer was performed to determine CI volume based on surgeon training. The prevalence of traditional candidates for CIs was estimated from US census population data and compared with the number of O&N providers. The ratio of audiologists to O&N providers was estimated from the Bureau of Labor and Statistics and American Speech‐Language‐Hearing Association databases.Results: From 2021 to 2023, a mean of 88% of providers performing ≥25 CIs per year and 90% performing ≥40 per year had training in O&N. All surgeons registering ≥100 implants per year were O&N providers. The mean percentage of O&N providers performing ≥25 CIs per year and ≥ 40 per year was higher than the percentage of General and Pediatric Otolaryngology providers performing the same volume: mean difference = 76%, p < 0.001 and mean difference = 79%, p < 0.001, respectively. The mean estimated prevalence of traditional CI candidates per O&N provider is 3,354 with an estimated mean of 32 audiologists (3.5 trained in CIs) per O&N provider.Conclusion: 88% of high‐volume CI surgeons have fellowship training in O&N. To meet the current state of CI underutilization and anticipated growing population of CI candidates, we propose increasing the surgical capacity of O&N providers and the number of surgeons proficient in CIs.Level of Evidence: NA Laryngoscope, 135:2146–2153, 2025


  • Long-term outcomes of pediatric temporal bone fractures with hearing loss: Results of a multinational database analysis

    by Jason L. Steele, Heather J. Smith, Samira Takkoush, Jumah G. Ahmad, Zachary D. Urdang, Neil S. Patel, Richard K. Gurgel, Mana Espahbodi


  • Open Access

    Management of bilateral head and neck paragangliomas at a single‐institution across four decades

    by Nikhil Bellamkonda, Evan L. Tooker, Anne Naumer, Luke O. Buchmann, Wendy Kohlmann, Hilary C. McCrary, Neil S. Patel, Mana Espahbodi

    Background: Bilateral head and neck paragangliomas (HNPGLs) require nuanced management to balance tumor control with functional preservation.Methods: All patients seen at a single‐institution for bilateral paraganglioma between 1983 and 2023 were retrospectively reviewed. Demographics, genetic testing results, and tumor characteristics were analyzed and compared to treatment modality and cranial nerve outcomes.Results: There were 49 patients with 116 tumors (90 carotid body tumors [CBTs], 15 vagal paragangliomas [VPs], and 11 jugular paragangliomas [JPs]). Twenty‐six patients had SDH pathologic variants (PV). Surgical management was more commonly utilized in younger patients (OR: 0.97, 95% CI: 0.950–0.992) and for JPs (OR: 9, 95% CI: 1.386–58.443). In surgical cases, CBTs had a lower risk of postoperative cranial nerve deficits compared to JPs and VPs (OR: 0.095, 95% CI: 0.013–0.692).Conclusions: Younger patients with bilateral HNPGLs, especially those with JP and CBT, are more often treated with surgery. CBTs have lowest risk of cranial nerve deficits after surgery.


  • Open Access

    Comparing Approaches for Repair of Superior Semicircular Canal Dehiscence

    by Evan L. Tooker, Christopher A. Hamilton, Samira Takkoush, Mana Espahbodi, Neil S. Patel, Richard K. Gurgel

    Objective: Compare outcomes for subjects who underwent middle cranial fossa (MCF) or transmastoid (TM) repair of superior semicircular canal dehiscence (SSCD).Study Design: Retrospective cohort study.Setting: Quaternary‐care, academic neurotology practice.Methods: Subjects who underwent MCF or TM repair of SSCD between December 1999 and April 2023 were identified. Main outcome measures included demographic data, length of surgery and hospital stay, clinical presentation, and audiometric testing.Results: Ninety‐three subjects (97 ears) who underwent surgery for SSCD met inclusion criteria: 58.8% (57) via MCF, 39.2% (38) via TM, and 2.0% (2) via TM + MCF. Median operative time was shorter for the TM (35) compared to the MCF (29) approach (118 vs 151 minutes, P < .001). Additionally, median hospital stays were shorter for TM (36) compared to the MCF (56) approach (15.3 vs 67.7 hours, P < .001). Overall, 92% (49/53) of MCF and 92% (33/36) of TM surgeries resulted in an improvement or resolution of one or more symptoms (P = .84). There was no significant preoperative to postoperative change in the median air conduction pure‐tone average (PTA), air‐bone gap, or word recognition score in both the MCF and TM groups (P > .05). Improvements of >10 dB in the pre‐ to postoperative absolute change in bone conduction PTA were noted in 3 subjects in the MCF group and 4 subjects in the TM group (P = .49).Conclusion: The TM approach for SSCD demonstrates shorter operative times and length of hospital stay. The TM and MCF approaches have comparable audiometric and clinical outcomes.


  • Analysis of Inflammatory Signaling in Human Middle Ear Cell Culture Models of Pediatric Otitis Media

    by Mana Espahbodi, Tina L. Samuels, Caroline McCormick, Pawjai Khampang, Ke Yan, Samuel Marshall, Michael E. McCormick, Robert H. Chun, Steven A. Harvey, David R. Friedland, et al.

    Objectives/Hypothesis: Cell culture models are valuable tools for investigation of the molecular pathogenesis of diseases including otitis media (OM). Previous study indicates that age‐, sex‐, and race‐associated differences in molecular signaling may impact disease pathophysiology. Currently, a singular immortalized middle ear epithelial (MEE) cell line exists, HMEEC‐1, derived from an adult without known middle ear disease. In this study, HMEEC‐1 and primary MEE cultures from pediatric patients with and without OM were stimulated with inflammatory cytokines or OM‐pathogenic bacterial lysates to examine differences in the response of molecules associated with OM pathogenesis.Study Design: Case–control series.Methods: MEE cultures were established from patients aged Haemophilus influenzae lysate. TNFA, IL1B, IL6, IL8, IL10, and MUC5B were assayed via quantitative polymerase chain reaction. IL‐8 was assayed by enzyme‐linked immunosorbent assay.Results: Gene/protein target expressions were frequently higher in pediatric OM lines than in HMEEC‐1 and Peds CI. HMEEC‐1 cells were frequently less responsive to stimuli than all pediatric lines. OME lines were often more responsive than ROM lines.Conclusions: OM may be associated with specific molecular phenotypes that are retained in primary cell culture. Adult‐derived HMEEC‐1 cells differ significantly in baseline expression and response of OM‐associated molecules relative to pediatric MEE cells. Work is underway to immortalize pediatric OM MEE cultures as improved tools for the OM research community.Level of Evidence: 4 Laryngoscope, 131:410–416, 2021